Contineum Therapeutics, Inc. (CTNM)

Contineum Therapeutics Statistics

Total Valuation

CTNM has a market cap or net worth of $475.29 million. The enterprise value is $220.64 million.

Market Cap	475.29M
Enterprise Value	220.64M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, before market open.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

CTNM has 37.34 million shares outstanding. The number of shares has increased by 43.14% in one year.

Current Share Class	32.67M
Shares Outstanding	37.34M
Shares Change (YoY)	+43.14%
Shares Change (QoQ)	+9.77%
Owned by Insiders (%)	0.84%
Owned by Institutions (%)	60.85%
Float	25.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.82
P/TBV Ratio	1.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 27.50, with a Debt / Equity ratio of 0.03.

Current Ratio	27.50
Quick Ratio	26.98
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.13% and return on invested capital (ROIC) is -1,375.07%.

Return on Equity (ROE)	-26.13%
Return on Assets (ROA)	-17.38%
Return on Invested Capital (ROIC)	-1,375.07%
Return on Capital Employed (ROCE)	-25.50%
Weighted Average Cost of Capital (WACC)	11.66%
Revenue Per Employee	n/a
Profits Per Employee	-$1.18M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +119.48% in the last 52 weeks. The beta is 1.38, so CTNM's price volatility has been higher than the market average.

Beta (5Y)	1.38
52-Week Price Change	+119.48%
50-Day Moving Average	14.15
200-Day Moving Average	10.74
Relative Strength Index (RSI)	44.36
Average Volume (20 Days)	362,927

Short Selling Information

The latest short interest is 2.64 million, so 7.08% of the outstanding shares have been sold short.

Short Interest	2.64M
Short Previous Month	2.55M
Short % of Shares Out	7.08%
Short % of Float	10.42%
Short Ratio (days to cover)	12.10

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-68.06M
Pretax Income	-59.98M
Net Income	-59.98M
EBITDA	-67.74M
EBIT	-68.06M
Earnings Per Share (EPS)	-$2.17

Balance Sheet

The company has $262.90 million in cash and $8.25 million in debt, with a net cash position of $254.65 million or $6.82 per share.

Cash & Cash Equivalents	262.90M
Total Debt	8.25M
Net Cash	254.65M
Net Cash Per Share	$6.82
Equity (Book Value)	260.99M
Book Value Per Share	6.99
Working Capital	258.17M

Cash Flow

In the last 12 months, operating cash flow was -$55.31 million and capital expenditures -$231,000, giving a free cash flow of -$55.54 million.

Operating Cash Flow	-55.31M
Capital Expenditures	-231,000
Depreciation & Amortization	323,000
Net Borrowing	n/a
Free Cash Flow	-55.54M
FCF Per Share	-$1.49

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.14%
Shareholder Yield	-43.14%
Earnings Yield	-12.62%
FCF Yield	-11.69%

Analyst Forecast

The average price target for CTNM is $19.00, which is 49.25% higher than the current price. The consensus rating is "Buy".

Price Target	$19.00
Price Target Difference	49.25%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	5.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2